SynDaver Labs Net Worth 2022

SynDaver Labs is a medical simulation and cadaver startup that focuses on the creation of high fidelity animal and human models. These models are designed to mimic the mechanical and biological characteristics of live tissues. Their models can be used for surgical and medical device studies. They are constructed from composites that are comprised of water, salts and fibers.

Founded in 2004, the company is focused on developing synthetic organs and human tissues for research and clinical training. The goal is to eliminate the use of real living animals in medical education. Using SynDaver’s tissue products, researchers will be able to test new devices and develop new procedures without having to worry about causing a fatal accident.

Despite its small size, the company has become a major player in the $2 billion global medical simulation market. Its flagship product is the “Synthetic Human,” which can be used in clinical and educational settings. In addition, the company plans to create new tissue 3D printers and dissection equipment.

SynDaver is headquartered in Tampa, Florida, and has a research facility in Phoenix. The company’s primary goals include creating and distributing lifelike synthetic human organs, and establishing a world-class library of living tissue properties. As part of its mission, SynDaver has created replica frogs that can be used for biology class dissections.

Although the company has not yet officially filed for an IPO, Sakezles has made it clear that he wants to go public. The CEO, who declined an offer by Shark Tank celebrity investor Robert Herjavec, says he will continue to operate SynDaver in the future. He also hopes to expand into new markets and introduce dissection equipment for high school and college students.

Since its inception, SynDaver has been featured on television shows such as Mythbusters, Grey’s Anatomy and Shark Tank. The company has sold its products to universities, and has generated more than $10 million in revenue over the past three years. Currently, the company has more than 100 employees. A spokesperson for the company has stated that it plans to add more employees and facilities in the United States in the near future.

Christopher Sakezles founded the company in 2004. After working at the University of Florida in the polymer sciences, he was inspired to create an artificial cadaver that would allow scientists to test medical devices and study human anatomy. With the assistance of researchers, he developed a substance that could be used to replicate the mechanical and biological characteristics of real tissues.

Sakezles has spent more than two decades building the company. In 2014, the company reported sales of $5 million. But the business is expected to double in sales in the next few years. When it comes to the valuation of the company, the information is scarce. The founder, however, is reportedly seeking $3 million for a 10% stake in the company.

In May 2015, Sakezles appeared on the popular television show Shark Tank, where he pitched the company to the panel of investors. One of the guests, Robert Herjavec, invested $3 million for a 25% stake in the company.